A Rare Case of Flavocoxid-Induced Pulmonary Fibrosis.

Authors

• Dimitrios Drekolias
• Naga Vaishnavi Gadela
• Philip Krupka
• Jennifer Broess
• Jason Jacob

Publication/Presentation Date

8-8-2020

Abstract

Pulmonary fibrosis is a chronic progressive interstitial lung disease characterized by repetitive cycles of epithelial cell injury and dysregulated repair. Although most cases of pulmonary fibrosis are idiopathic, a detailed history that includes medications, comorbidities, tobacco use, environmental exposures, and family history should be taken to rule out secondary etiology. We present a case of flavocoxid-induced pulmonary toxicity which progressed from hypersensitivity pneumonitis to pulmonary fibrosis even after discontinuation of the offending drug.

Volume

12

Issue

8

First Page

9617

Last Page

9617

ISSN

2168-8184

Published In/Presented At

Drekolias, D., Gadela, N. V., Krupka, P., Broess, J., & Jacob, J. (2020). A Rare Case of Flavocoxid-Induced Pulmonary Fibrosis. Cureus, 12(8), e9617. https://doi.org/10.7759/cureus.9617

Disciplines

Medicine and Health Sciences

PubMedID

32923218

Department(s)

Department of Medicine

Document Type

Article